Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. - Wikidata - awgldk - TriplyDB

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

http://www.wikidata.org/entity/Q53551598

about

Sublingual immunotherapy for asthma Induction of tolerance via the sublingual route: mechanisms and applications Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis.Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method.Allergen immunotherapy: current and new therapeutic strategies.Immunotherapy in atopic dermatitis.Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma.Immune mechanisms of allergen-specific sublingual immunotherapy.Different methods of local allergen-specific immunotherapy.The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso The safety of sublingual-swallow immunotherapy: an analysis of published studies.Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.Efficacy and safety of allergen-specific immunotherapy in rhinitis, rhinoconjunctivitis, and bee/wasp venom allergies.Sublingual immunotherapy in the treatment of children.Sublingual immunotherapy of allergic diseases.Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper.Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy.Efficacy of long-term sublingual-oral immunotherapy in allergic rhinitis.Mechanisms of sublingual immunotherapy.Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes.Emerging sublingual immunotherapy drugs.How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Clinically significant variability of serum IgE concentrations in patients with severe asthma.Novel routes for allergen immunotherapy: safety, efficacy and mode of action.Dropouts in sublingual allergen immunotherapy trials - a systematic review.Monitoring of occupational and environmental aeroallergens-- EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy and Aerobiology & Air Pollution.A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy.Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications.Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites.Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites.Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial.

P2860

Q24187736-4FE49B8E-4125-429A-8F5D-37B5046A0980 Q27022140-F24199EE-5992-4E12-87F3-89CD76B2FDE1 Q30234365-132AA906-0E5E-411B-8528-919E3733D43E Q33255883-272E3331-4156-4F56-9482-A7AB0702CDE9 Q34074753-4D29ED0C-EAB0-4209-A4C6-EB3882C70522 Q34104585-7B2C92EF-8891-4FBF-98E2-4D482429A168 Q34375745-B9628BC3-33F1-43CC-80A1-8632D2252A63 Q34484071-63C1502E-E87D-4D76-BE70-7A6B9B321A4C Q34612153-60A29402-9FFB-4772-8774-6B85EC7EE0F5 Q35005943-E6603685-7145-4D63-89BF-83C9E7839733 Q35777126-69536045-9085-42C8-8DE9-D45E66BF8B88 Q36130311-33CA1666-6DA3-4FBF-BF4A-C8967AB4BD8F Q36157889-FD2CAAEB-FAE1-43F8-AB6A-D2CC7460718E Q36327394-A7A3C170-ED7B-4FE0-8840-3553BB5C1D29 Q36515380-DF9F6D0C-57D6-4489-89AD-FFB27BCBA316 Q36583727-7F340A97-89CD-4A68-8519-DFF171FBB309 Q36834756-DCC645DC-A0F1-4D1B-9BC3-E1FF0287D858 Q36946146-783ADCCE-D145-4C92-BEEF-F9A31953ACBF Q37091822-29C18822-7A3B-4806-8029-AA31367876D7 Q37502904-7AAE5C34-2896-4BFF-A651-24958E7C01F1 Q37550576-68A1F1B5-A308-4080-B293-8AA9EE77C4A8 Q37625553-CC657F3D-2EFE-44A3-AA7E-66EF311CD85D Q37801372-0DDD38E4-24F0-4FDA-9D2F-654B5D23F88B Q37865584-128BE772-501B-43F5-9C08-58F76E49B1C6 Q37978678-F1CE0461-D2D9-4A01-9AA4-B31132002AE8 Q37984572-8E615D3B-EDB6-4928-BC0C-A915B3578D60 Q38199748-130E7E92-8097-4C2B-9D9B-7C39EB6EDB6E Q38217435-83879BB6-7F40-4726-B940-1AEEE3A1CBD1 Q38262772-FD6614C6-F29A-42A1-8833-2D2FB19C74E9 Q38533962-7B548416-966A-4EBD-B36B-B66F1EBBB498 Q39115606-B1335D9E-049F-4355-B38F-820D1258F703 Q39649421-F1893320-101D-4A81-A8D1-95B244BCD6F6 Q39686005-EC990075-4689-4D6D-B3A3-2EB81A8A953A Q40544021-1362F731-DD06-448F-B3E5-B883B12D8BBF Q41776008-A501412A-3C8F-4805-B2A7-BF2A72A117F8 Q43724345-A33DE356-D9BA-420E-B654-03C0CFE03647 Q43795644-41A5CF53-B944-4914-9BFD-3E15E706F247 Q44290592-CD4C8C1A-627D-435C-B22A-8DAF52FFF76C Q44488880-B00DC76D-0862-42F8-911D-EDA9B83C97D6 Q44961338-B3D256AD-5D2D-4F99-84BE-C63198D6CECA

P2860

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

http://www.wikidata.org/entity/Q53551598

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@en

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@nl

type

label

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@en

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@nl

prefLabel

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@en

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@nl

P1433

Q53551598-DA3A1E74-B832-4975-AC08-6F48FC940BC4

P1476

Q53551598-761F254D-0972-498A-8B75-0D163B4F0640

P2093

Q53551598-03470E7C-BCE2-462E-9BB2-18A0AA49C339

Q53551598-040BBA0A-5460-4ECF-99F3-8F947010A4E2

Q53551598-27318C4B-86F2-40C7-B6DD-C06DF0DE12E2

Q53551598-39B13D3A-F829-40AC-9574-421C636FCFD9

Q53551598-3F876CC5-9F2B-4091-918E-6DEB5907D99F

Q53551598-62D4CBED-24FE-4C89-BDEB-8318D8D68BAE

Q53551598-73CEE6C8-9188-44B0-AD3B-4E4F2A629869

Q53551598-B9304AC1-BFAA-45AF-A1EF-AFD171463BD3

Q53551598-CC22925C-E5E5-4468-965E-81D0D33A6488

Q53551598-CF130808-A4FF-43D9-8E19-1AA44577AFF3

P2860

Q53551598-1325F522-E488-44C5-AA78-824BEDA5BB24

Q53551598-4180A416-C994-43EE-A824-FC445B3B8B93

Q53551598-4460DAB0-59DC-4C4E-9387-C5FCD185222F

Q53551598-47D25CF5-12E1-4E12-8CE4-DF26860424F9

Q53551598-5E82014B-BF35-49E9-AD97-358BBA78C2A2

Q53551598-889E5F60-D1F6-4105-B334-2354C1572490

Q53551598-D06FC748-9EFB-41CA-BDF1-D59097051B81

Q53551598-F649AA94-668A-45B9-BFA2-D8BA44EE8157

P304

Q53551598-57548EE5-B3C2-4ACD-A518-3041F9E64240

P31

Q53551598-B96B178D-F2CF-4E4A-BB4A-D95B4B1B08AA

P356

Q53551598-B0E071D3-57BE-4B9D-A8C6-572A006A578C

P433

Q53551598-04DD8CA3-DF4F-4982-BFEF-60BF64411D49

P478

Q53551598-9B85698E-4B03-4B26-B135-ACDD52CF48AE

P577

Q53551598-D7DA615D-6EE3-40CB-B73E-ED117428DAC8

P5875

Q53551598-E9B12879-7D99-4EC2-8F58-9687415FC24D

P698

Q53551598-4CAE5C6C-3511-41E0-BF23-6DFB617FFEED

P921

Q53551598-2E582851-7BCC-4BAB-A630-17186022A402

Q53551598-4578E035-6897-486C-9DFF-B5F5822B903F

Q53551598-65D2C11B-F199-4B9E-94FA-A52607F3F4C2

Q53551598-7E44932F-80A0-4BDD-BA1C-CFBAFACA9636

P356

J.1398-9995.1999.00916.X

P1433

P1476

Sublingual-swallow immunothera ...... ind, placebo-controlled study.

@en

P2093

André C

http://www.w3.org/2001/XMLSchema#string

Bousquet J

http://www.w3.org/2001/XMLSchema#string

Caillaud D

http://www.w3.org/2001/XMLSchema#string

Dubost R

http://www.w3.org/2001/XMLSchema#string

Galvain S

http://www.w3.org/2001/XMLSchema#string

Guinnepain MT

http://www.w3.org/2001/XMLSchema#string

Herman D

http://www.w3.org/2001/XMLSchema#string

Leynadier F

http://www.w3.org/2001/XMLSchema#string

Pauli G

http://www.w3.org/2001/XMLSchema#string

Perrin-Fayolle M

http://www.w3.org/2001/XMLSchema#string

P2860

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Heterogeneity of bronchial asthma. Sub-populations--or different stages of the disease.

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract.

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma.

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.

A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

P304

249-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1398-9995.1999.00916.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12976249

http://www.w3.org/2001/XMLSchema#string

P698

10321561

http://www.w3.org/2001/XMLSchema#string

P921